Home » Topics » Disease categories and therapies » Cancer

Cancer
RSS

Albert Einstein College of Medicine claims new Tim16 inhibitors

Nov. 17, 2010

Wyeth describes new PI3K-alpha/gamma and mTOR inhibitors

Nov. 17, 2010

Merrion Pharma plans phase III study of Orazol in breast cancer

Nov. 16, 2010

Agios Pharma claims new activators of pyruvate kinase isozymes M1/M2

Nov. 16, 2010

FDA approves Eisai's Halaven for late-stage breast cancer

Nov. 16, 2010

Karus Therapeutics claims new histone deacetylase inhibitors

Nov. 16, 2010

Italian scientists discover new selective androgen receptor modulators

Nov. 16, 2010

Nektar Therapeutics presents new tyrosine protein kinase inhibitor-oligomer conjugates

Nov. 16, 2010

AB Therapeutics reports data on two anticancer agents in model of NSCLC

Nov. 16, 2010

Epeius Biotech gets U.S. federal grant to further develop Rexin-G

Nov. 15, 2010

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 24, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for April 21, 2026
A free gene therapy? Regeneron’s Otarmeni approved for hearing loss
BioWorld
Children and adults with a type of congenital hearing loss now have a free treatment option, with the U.S. FDA’s accelerated approval of Regeneron Pharmaceuticals...
Psychedelic space expanding on Trump’s EO
BioWorld
Timothy Leary is dead, but he could be on the outside looking in with a smile on his face as U.S. President Donald Trump’s latest executive order (EO) fuels a...
At AACR: Epigenetic fingerprints in metastases track tumor origin
BioWorld
When a tumor migrates and colonizes another tissue or organ, it can be identified as a metastasis, but its origin is not always clear. Now, a study based on...